BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 28774772)

  • 1. Cardiovascular Health, Erectile Dysfunction, and Testosterone Replacement: Controversies and Correlations.
    Elkhoury FF; Rambhatla A; Mills JN; Rajfer J
    Urology; 2017 Dec; 110():1-8. PubMed ID: 28774772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data.
    Alwani M; Yassin A; Talib R; Al-Qudimat A; Aboumarzouk O; Al-Zoubi RM; Saad F; Haider KS; Al Ansari A
    Vasc Health Risk Manag; 2021; 17():497-508. PubMed ID: 34465997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism.
    Pencina KM; Travison TG; Cunningham GR; Lincoff AM; Nissen SE; Khera M; Miller MG; Flevaris P; Li X; Wannemuehler K; Bhasin S
    J Clin Endocrinol Metab; 2024 Jan; 109(2):569-580. PubMed ID: 37589949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Update of the 2010 Endocrine Society Clinical Practice Guidelines for Male Hypogonadism: A Systematic Analysis.
    Seftel AD; Kathrins M; Niederberger C
    Mayo Clin Proc; 2015 Aug; 90(8):1104-15. PubMed ID: 26205546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State-of-the-Art: a Review of Cardiovascular Effects of Testosterone Replacement Therapy in Adult Males.
    Elsherbiny A; Tricomi M; Bhatt D; Dandapantula HK
    Curr Cardiol Rep; 2017 Apr; 19(4):35. PubMed ID: 28361372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
    Afiadata A; Ellsworth P
    Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk.
    Maganty A; Osterberg EC; Ramasamy R
    Am J Mens Health; 2015 Jul; 9(4):340-4. PubMed ID: 24972716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypogonadism in the man with erectile dysfunction: what to look for and when to treat.
    Lazarou S; Morgentaler A
    Curr Urol Rep; 2005 Nov; 6(6):476-81. PubMed ID: 16238923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erectile dysfunction and hypogonadism (low testosterone).
    Barkin J
    Can J Urol; 2011 Apr; 18 Suppl():2-7. PubMed ID: 21501544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging link between hypogonadism and metabolic syndrome.
    Guay AT
    J Androl; 2009; 30(4):370-6. PubMed ID: 18772486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction.
    Guay AT; Traish A
    Urol Clin North Am; 2011 May; 38(2):175-83. PubMed ID: 21621084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular issues in hypogonadism and testosterone therapy.
    Shabsigh R; Katz M; Yan G; Makhsida N
    Am J Cardiol; 2005 Dec; 96(12B):67M-72M. PubMed ID: 16387571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Testosterone in the Elderly: What Do We Know?
    Barone B; Napolitano L; Abate M; Cirillo L; Reccia P; Passaro F; Turco C; Morra S; Mastrangelo F; Scarpato A; Amicuzi U; Morgera V; Romano L; Calace FP; Pandolfo SD; De Luca L; Aveta A; Sicignano E; Trivellato M; Spena G; D'Alterio C; Fusco GM; Vitale R; Arcaniolo D; Crocetto F
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen replacement in men with hypogonadism and erectile dysfunction.
    Albrecht-Betancourt M; Hijazi RA; Cunningham GR
    Endocrine; 2004; 23(2-3):143-8. PubMed ID: 15146093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgens and erectile function: a case for early androgen use in postprostatectomy hypogonadal men.
    Khera M
    J Sex Med; 2009 Mar; 6 Suppl 3():234-8. PubMed ID: 19207279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Testosterone therapy].
    Diemer T; Hauptmann A; Wagenlehner FM
    Urologe A; 2016 Apr; 55(4):539-48; quiz 549-50. PubMed ID: 27067659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortality.
    Saad F; Caliber M; Doros G; Haider KS; Haider A
    Aging Male; 2020 Mar; 23(1):81-92. PubMed ID: 30782054
    [No Abstract]   [Full Text] [Related]  

  • 18. The Effect of Testosterone Replacement Therapy on Penile Hemodynamics in Hypogonadal Men With Erectile Dysfunction, Having Veno-Occlusive Dysfunction.
    Efesoy O; Çayan S; Akbay E
    Am J Mens Health; 2018 May; 12(3):634-638. PubMed ID: 29575969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of the "aging male"].
    Diemer T; Hauck EW; Rohde V; Weidner W
    Urologe A; 2005 Oct; 44(10):1173-8. PubMed ID: 16151757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone replacement therapy and cardiovascular events.
    Çatakoğlu AB; Kendirci M
    Turk Kardiyol Dern Ars; 2017 Oct; 45(7):664-672. PubMed ID: 28990951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.